查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1941213

神經刺激設備市場報告：按刺激類型、設備類型、應用、最終用戶和地區分類（2026-2034 年）

Neurostimulation Devices Market Report by Stimulation Type, Device Type, Application, End-User, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 147 Pages | 商品交期: 2-3個工作天內

價格

2025年，全球神經刺激設備市場規模達105億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到233億美元，2026年至2034年的複合年成長率為8.83%。推動市場成長的關鍵因素包括人口老化和醫療費用支出增加、非侵入性或微創神經刺激技術的發展，以及政府和私人醫療保險公司報銷政策的改善。

神經刺激設備是一種先進的醫療技術，旨在調節和影響人體內神經活動。這些設備透過向神經系統的特定區域傳遞電脈衝或磁脈衝來發揮作用，旨在緩解各種神經系統疾病和慢性病症。它們提供了一種前景廣闊的非侵入性或微創治療方法，有望改善患者的生活品質，並為治療各種神經系統疾病開闢新的可能性。神經刺激設備主要分為兩大類：深部腦部刺激（DBS）和脊髓刺激。 DBS 使用植入特定腦區的電極來調節異常神經訊號，治療帕金森氏症、自發性震顫和肌張力不全症等疾病。

人口老化正在推動全球市場的發展。隨著老年人口的成長，對用於治療相關疾病的神經刺激設備的需求預計將會上升。此外，非侵入性或微創神經刺激技術的發展正在擴大潛在患者群體，因為與傳統手術相比，這些技術通常風險更低、恢復期更短。同時，一些地區政府和私人醫療保險公司改善的報銷政策也使患者更容易獲得神經刺激治療，進一步推動了市場成長。此外，正在進行的研究和臨床試驗也為神經刺激設備的安全性和有效性提供了更多證據。這些研究的積極結果正在增強醫療專業人員和患者對該技術的信任。此外，不斷成長的醫療費用支出也支持了市場解決方案的成長，因為神經刺激設備為慢性病管理提供了一種經濟有效的方法，從而推動了其應用。

神經刺激設備市場趨勢及促進因素：

神經系統疾病盛行率不斷上升

神經系統疾病，例如帕金森氏症、癲癇、慢性疼痛和憂鬱症，影響全球數百萬人，並給醫療保健成本帶來沉重負擔。對於對傳統療法無反應或出現嚴重副作用的患者而言，神經刺激設備提供了極具前景的解決方案。深部腦部刺激（DBS）在治療帕金森氏症等運動障礙方面展現出顯著療效，推動了對這類設備的需求。此外，慢性疼痛發生率的上升，尤其是在人口老化和久坐生活方式的影響下，也促使人們對脊髓刺激（SCS）設備的需求日益成長，這類設備能夠在緩解疼痛的同時顯著減少對藥物的依賴。隨著各國政府和醫療機構將改善患者預後作為優先事項並尋求創新解決方案，預計對神經刺激設備的需求將穩定成長。

神經刺激技術的持續進步

持續的研發工作正推動更先進、更具針對性的神經刺激設備的研發。創新技術包括更小巧、更精準的電極、更長的電池壽命，以及整合封閉回路型系統，可根據患者的即時需求自動調節刺激參數。這些進步提高了治療效果，減少了副作用，並提升了患者的舒適度。此外，微創植入神經刺激設備技術的開發使其能夠應用於更廣泛的患者群體，使治療更易於獲得，並吸引更多患者和醫療服務提供者。隨著技術的不斷發展，神經刺激設備將變得更加高效和適應性更強，從而進一步加速其普及和市場滲透。

提高人們對神經調控療法的認知與接受度

隨著越來越多的臨床證據證實神經刺激設備在治療各種神經系統疾病的有效性，醫療專業人員也越來越傾向於向患者推薦這些治療方法。此外，患者權益倡導組織和宣傳宣傳活動在教育大眾了解神經刺激療法的潛在益處方面發揮關鍵作用，從而提高了患者對該療法的接受度。一些患者透過神經刺激設備顯著改善了生活品質，他們的成功案例進一步提升了人們對這些治療方法的積極認知。隨著人們對神經調控技術的信心不斷增強，預計對這些設備的需求將會增加，從而推動市場擴張。此外，醫療機構、研究人員和設備製造商之間的合作，旨在提高公眾認知並確保合理使用，也將有助於神經刺激設備市場的持續成長。

目錄

第1章：序言

第2章：調查範圍與調查方法

  • 調查目標
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 二手資訊
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 調查方法

第3章執行摘要

第4章 引言

第5章：全球神經刺激設備市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 按刺激類型分類的市場區隔

  • 內部刺激
  • 外部刺激

第7章 按設備類型分類的市場區隔

  • 脊髓刺激（SCS）裝置
  • DBS（深部腦部刺激）裝置
  • 薦椎神經刺激（SNS）裝置
  • 迷走神經刺激（VNS）裝置
  • 胃電刺激（GES）裝置
  • 經皮電神經刺激設備
  • 經顱磁刺激裝置
  • 其他

第8章 按應用分類的市場細分

  • 疼痛管理
  • 癲癇
  • 自發性震顫
  • 尿失禁和糞便失禁
  • 憂鬱症
  • 肌張力不全症
  • 帕金森氏症
  • 其他

第9章 依最終用戶分類的市場細分

  • 復健中心
  • 醫院
  • 診所
  • 其他

第10章 按地區分類的市場細分

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第11章 SWOT 分析

第12章 價值鏈分析

第13章 波特五力分析

第14章 物價指數

第15章 競爭格局

  • 市場結構
  • 主要企業
  • 主要企業簡介
    • Biocontrol Medical
    • Boston Scientific Corporation
    • Cyberonics Inc.
    • Medtronic Inc.
    • Neuronetics Inc.
    • Neuropace Inc.
    • Neurosigma Inc.
    • Nevro Corporation
    • ST. Jude Medical Inc.
    • Synapse Biomedical Inc.
Product Code: SR112026A1892

The global neurostimulation devices market size reached USD 10.5 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 23.3 Billion by 2034, exhibiting a growth rate (CAGR) of 8.83% during 2026-2034. The growing aging population coupled with the rising healthcare expenditure, development of non-invasive or minimally invasive neurostimulation technologies, and improved reimbursement policies by government and private health insurers are some of the major factors propelling the market.

Neurostimulation devices are advanced medical technologies designed to modulate and influence neural activity within the human body. These devices work by delivering electrical or magnetic impulses to specific regions of the nervous system, aiming to alleviate various neurological conditions and chronic disorders. They offer a promising non-invasive or minimally invasive therapeutic approach, enhancing the quality of life for patients and potentially opening up new avenues for treating various neurological disorders. The two primary types of neurostimulation devices are deep brain stimulation and spinal cord stimulation. DBS involves implanting electrodes into targeted brain areas to regulate abnormal neural signals and treat conditions such as Parkinson's disease, essential tremor, and dystonia.

The growing aging population is driving the global market. As the elderly population grows, the demand for neurostimulation devices to manage these conditions is likely to rise. Moreover, the development of non-invasive or minimally invasive neurostimulation technologies has expanded the potential patient pool, as these options often offer reduced risks and quicker recovery times compared to traditional surgical procedures. Besides, improved reimbursement policies by government and private health insurers in some regions have made neurostimulation treatments more accessible to patients, encouraging market growth. Also, ongoing research and clinical trials have provided additional evidence for the safety and efficacy of neurostimulation devices. Positive results from these studies have increased confidence in the technology among medical professionals and patients. Furthermore, the rising healthcare expenditure is supporting the growth of market solutions as neurostimulation devices offer a cost-effective approach to managing chronic conditions, which has driven their adoption.

Neurostimulation Devices Market Trends/Drivers:

Increasing Prevalence of Neurological Disorders

Neurological conditions such as Parkinson's disease, epilepsy, chronic pain, and depression affect millions of people worldwide, leading to significant healthcare burdens. Neurostimulation devices offer a promising solution for patients who are refractory to conventional treatments or experience severe side effects. Deep brain stimulation (DBS) has demonstrated remarkable efficacy in managing movement disorders, such as Parkinson's disease, thereby augmenting the demand for these devices. Additionally, the escalating incidence of chronic pain, particularly due to aging populations and sedentary lifestyles, fuels the need for spinal cord stimulation (SCS) devices to provide pain relief without relying heavily on medications. As governments and healthcare organizations prioritize improved patient outcomes and seek innovative solutions, the demand for neurostimulation devices is expected to grow steadily.

Continual Advancements in Neurostimulation Technologies

Continuous research and development efforts have led to the creation of more sophisticated and targeted neurostimulation devices. Innovations include smaller and more precise electrodes, improved battery life, and the integration of closed-loop systems that can automatically adjust stimulation parameters based on real-time patient needs. These advancements translate to enhanced treatment outcomes, reduced side effects, and increased patient comfort. Moreover, the development of minimally invasive procedures for implanting neurostimulation devices has expanded their applicability to a broader patient population, making the treatments more accessible and appealing to both patients and healthcare providers. As technology continues to evolve, neurostimulation devices will likely become even more efficient and adaptable, further impelling their adoption and market penetration.

Growing Awareness and Acceptance of Neuromodulation Therapies

As more clinical evidence supports the effectiveness of neurostimulation devices in treating various neurological disorders, medical practitioners increasingly recommend these therapies to their patients. Additionally, patient advocacy groups and awareness campaigns have played a crucial role in educating individuals about the potential benefits of neurostimulation, leading to greater patient acceptance of these treatments. The success stories of patients who have experienced significant improvements in their quality of life through neurostimulation devices have further contributed to the positive perception of these therapies. As trust in neuromodulation grows, the demand for these devices is expected to increase, fuelling the market expansion. Furthermore, collaborations between healthcare organizations, researchers, and device manufacturers to spread awareness and ensure appropriate usage will contribute to the sustained growth of the neurostimulation devices market.

Neurostimulation Devices Industry Segmentation:

Breakup by Stimulation Type:

  • Internal Stimulation
  • External Stimulation

Internal stimulation devices form a significant segment within the neurostimulation market, characterized by their implantable nature. These devices are surgically placed within the body to deliver targeted electrical or magnetic stimulation directly to specific neural structures. The demand for internal stimulation devices is driven by their efficacy in managing complex neurological disorders that do not respond adequately to medications or other treatments. The ability to precisely target neural circuits while providing reversible and adjustable stimulation parameters enhances treatment outcomes, leading to improved patient quality of life.

On the other hand, external stimulation devices represent another substantial segment in the neurostimulation market, characterized by their non-invasive or minimally invasive nature. These devices are applied externally to the body's surface, delivering stimulation without the need for surgical implantation.

Breakup by Device Type:

  • SCS (Spinal Cord Stimulation) Devices
  • DBS (Deep Brain Stimulation) Devices
  • SNS (Sacral Nerve Stimulation) Devices
  • VNS (Vagus Nerve Stimulation) Devices
  • GES (Gastric Electrical Stimulation) Devices
  • Transcutaneous Electrical Nerve Stimulation Devices
  • Transcranial Magnetic Stimulation Devices
  • Others

SCS (spinal cord stimulation) dominates the market

SCS involves the implantation of electrodes along the spinal cord, where electrical impulses are delivered to modulate pain signals and provide relief for chronic pain conditions. The minimally invasive nature of the procedure offers numerous benefits, including shorter recovery times and reduced risks compared to invasive surgeries. Additionally, the customizable nature of SCS allows for individualized programming to target specific pain areas, tailoring treatment to meet each patient's unique needs. Moreover, continual advancements in SCS technology have led to more sophisticated devices with improved battery life, smaller implants, and enhanced programming capabilities, providing greater patient comfort and long-term sustainability. The focus on patient-centered care and shared decision-making has led to an increased emphasis on personalized pain management plans. Spinal cord stimulation, with its individualized programming capabilities, aligns well with this patient-centric approach, fueling its adoption in pain management strategies.

Breakup by Application:

  • Pain Management
  • Epilepsy
  • Essential Tremors
  • Urinary and Fecal Incontinence
  • Depression
  • Dystonia
  • Parkinson's Disease
  • Others

Pain management dominates the market

Neurostimulation devices designed for pain management offer a promising alternative, particularly spinal cord stimulation (SCS) and peripheral nerve stimulation (PNS). These technologies work by delivering controlled electrical impulses to target nerves, modulating pain signals, and thereby reducing the perception of pain. Pain management through neurostimulation has demonstrated remarkable efficacy in various chronic pain conditions, including neuropathic pain, failed back surgery syndrome (FBSS), and complex regional pain syndrome (CRPS). Additionally, the advancements in neurostimulation technology have led to more personalized and precise pain management solutions, allowing for tailored treatment strategies based on individual patient needs.

Breakup by End-User:

  • Rehabilitation Centers
  • Hospitals
  • Medical Clinics
  • Others

Hospitals dominates the market

Hospitals play a central role in the diagnosis, treatment, and management of various neurological and chronic disorders, which often require neurostimulation therapies as part of the treatment plan. Hospitals have access to multidisciplinary teams of medical professionals, including neurologists, neurosurgeons, pain specialists, and anesthesiologists, who collaborate to provide comprehensive care to patients requiring neurostimulation therapies. Additionally, they are equipped with state-of-the-art operating rooms and facilities that meet stringent regulatory standards, ensuring safe and effective implantation procedures. Furthermore, neurostimulation devices often require careful programming and adjustments to optimize treatment outcomes, and hospitals have the resources to support these ongoing patient management needs.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America exhibits a clear dominance, accounting for the largest neurostimulation devices market share.

The report has also provided a comprehensive analysis of all the major regional markets, which includes North America (the United States and Canada), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and Others), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and Others), Latin America (Brazil, Mexico, and Others), and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America has a well-established healthcare infrastructure and is at the forefront of medical research and technological advancements. The presence of leading healthcare facilities, specialized neurology centers, and renowned research institutions fosters innovation and the adoption of cutting-edge neurostimulation technologies. Moreover, the region has a high prevalence of neurological disorders and chronic pain conditions, leading to a substantial demand for neurostimulation devices for effective management and treatment. The region's aging population, coupled with a growing awareness of neurostimulation therapies among patients and healthcare providers, further fuels market growth. Additionally, favorable reimbursement policies and regulatory frameworks in North America support the widespread adoption of neurostimulation devices.

Competitive Landscape:

Neurostimulation device manufacturers are heavily investing in research and development to enhance their existing products and develop new, innovative technologies. This involves conducting clinical trials, exploring new applications for neurostimulation, and improving the safety and efficacy of their devices. Moreover, companies are introducing new neurostimulation devices or release upgraded versions of existing ones. These launches aim to provide patients and healthcare professionals with state-of-the-art solutions that offer better outcomes and user experiences. Furthermore, companies actively seek to expand their market presence, both geographically and in terms of applications. They may pursue regulatory approvals in different regions, explore new therapeutic areas for neurostimulation, or target specific patient populations with unmet needs. Also, collaboration with other companies, research institutions, and healthcare organizations is common in the neurostimulation devices market.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • Biocontrol Medical
  • Boston Scientific Corporation
  • Cyberonics Inc.
  • Medtronic Inc.
  • Neuronetics Inc.
  • Neuropace Inc.
  • Neurosigma Inc.
  • Nevro Corporation
  • ST. Jude Medical Inc.
  • Synapse Biomedical Inc.

Key Questions Answered in This Report

  • 1.What was the size of the global neurostimulation devices market in 2025?
  • 2.What is the expected growth rate of the global neurostimulation devices market during 2026-2034?
  • 3.What are the key factors driving the global neurostimulation devices market?
  • 4.What has been the impact of COVID-19 on the global neurostimulation devices market?
  • 5.What is the breakup of the global neurostimulation devices market based on the device type?
  • 6.What is the breakup of the global neurostimulation devices market based on the application?
  • 7.What is the breakup of the global neurostimulation devices market based on the end-user?
  • 8.What are the key regions in the global neurostimulation devices market?
  • 9.Who are the key players/companies in the global neurostimulation devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Neurostimulation Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Stimulation Type

  • 6.1 Internal Stimulation
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 External Stimulation
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Device Type

  • 7.1 SCS (Spinal Cord Stimulation) Devices
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 DBS (Deep Brain Stimulation) Devices
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 SNS (Sacral Nerve Stimulation) Devices
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 VNS (Vagus Nerve Stimulation) Devices
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 GES (Gastric Electrical Stimulation) Devices
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Transcutaneous Electrical Nerve Stimulation Devices
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast
  • 7.7 Transcranial Magnetic Stimulation Devices
    • 7.7.1 Market Trends
    • 7.7.2 Market Forecast
  • 7.8 Others
    • 7.8.1 Market Trends
    • 7.8.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Pain Management
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Epilepsy
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Essential Tremors
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Urinary and Fecal Incontinence
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Depression
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Dystonia
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast
  • 8.7 Parkinson's Disease
    • 8.7.1 Market Trends
    • 8.7.2 Market Forecast
  • 8.8 Others
    • 8.8.1 Market Trends
    • 8.8.2 Market Forecast

9 Market Breakup by End-User

  • 9.1 Rehabilitation Centers
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Hospitals
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Medical Clinics
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Europe
    • 10.2.1 Germany
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 France
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 United Kingdom
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 Italy
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Spain
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Russia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Asia Pacific
    • 10.3.1 China
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 Japan
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 India
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 South Korea
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Australia
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Indonesia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

  • 12.1 Overview
  • 12.2 Inbound Logistics
  • 12.3 Operations
  • 12.4 Outbound Logistics
  • 12.5 Marketing and Sales
  • 12.6 Post Sales Services

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Indicators

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Biocontrol Medical
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Boston Scientific Corporation
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Cyberonics Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Medtronic Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Neuronetics Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
    • 15.3.6 Neuropace Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Neurosigma Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Nevro Corporation
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
    • 15.3.9 ST. Jude Medical Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 Synapse Biomedical Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio

List of Figures

  • Figure 1: Global: Neurostimulation Devices Market: Major Drivers and Challenges
  • Figure 2: Global: Neurostimulation Devices Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Neurostimulation Devices Market: Breakup by Stimulation Type (in %), 2025
  • Figure 4: Global: Neurostimulation Devices Market: Breakup by Device Type (in %), 2025
  • Figure 5: Global: Neurostimulation Devices Market: Breakup by Application (in %), 2025
  • Figure 6: Global: Neurostimulation Devices Market: Breakup by End-User (in %), 2025
  • Figure 7: Global: Neurostimulation Devices Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Neurostimulation Devices Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 9: Global: Neurostimulation Devices (Internal Stimulation) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 10: Global: Neurostimulation Devices (Internal Stimulation) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: Neurostimulation Devices (External Stimulation) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Neurostimulation Devices (External Stimulation) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Neurostimulation Devices (Spinal Cord Stimulation Devices) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Neurostimulation Devices (Spinal Cord Stimulation Devices) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Neurostimulation Devices (Deep Brain Stimulation Devices) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Neurostimulation Devices (Deep Brain Stimulation Devices) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Neurostimulation Devices (Sacral Nerve Stimulation Devices) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Neurostimulation Devices (Sacral Nerve Stimulation Devices) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Neurostimulation Devices (Vagus Nerve Stimulation Devices) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Global: Neurostimulation Devices (Vagus Nerve Stimulation Devices) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Global: Neurostimulation Devices (Gastric Electrical Stimulation Devices) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Global: Neurostimulation Devices (Gastric Electrical Stimulation Devices) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: Global: Neurostimulation Devices (Transcutaneous Electrical Nerve Stimulation Devices) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: Global: Neurostimulation Devices (Transcutaneous Electrical Nerve Stimulation Devices) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Global: Neurostimulation Devices (Transcranial Magnetic Stimulation Devices) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Global: Neurostimulation Devices (Transcranial Magnetic Stimulation Devices) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: Global: Neurostimulation Devices (Other Devices) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: Global: Neurostimulation Devices (Other Devices) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: Global: Neurostimulation Devices (Pain Management) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: Global: Neurostimulation Devices (Pain Management) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: Global: Neurostimulation Devices (Epilepsy) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: Global: Neurostimulation Devices (Epilepsy) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: Global: Neurostimulation Devices (Essential Tremors) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: Global: Neurostimulation Devices (Essential Tremors) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: Global: Neurostimulation Devices (Urinary and Fecal Incontinence) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: Global: Neurostimulation Devices (Urinary and Fecal Incontinence) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: Global: Neurostimulation Devices (Depression) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: Global: Neurostimulation Devices (Depression) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: Global: Neurostimulation Devices (Dystonia) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: Global: Neurostimulation Devices (Dystonia) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: Global: Neurostimulation Devices (Parkinson's Disease) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: Global: Neurostimulation Devices (Parkinson's Disease) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: Global: Neurostimulation Devices (Other Applications) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: Global: Neurostimulation Devices (Other Applications) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: Global: Neurostimulation Devices (Rehabilitation Centers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: Global: Neurostimulation Devices (Rehabilitation Centers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: Global: Neurostimulation Devices (Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: Global: Neurostimulation Devices (Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: Global: Neurostimulation Devices (Medical Clinics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: Global: Neurostimulation Devices (Medical Clinics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: Global: Neurostimulation Devices (Others) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: Global: Neurostimulation Devices (Others) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: North America: Neurostimulation Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: North America: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: United States: Neurostimulation Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: United States: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: Canada: Neurostimulation Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: Canada: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: Europe: Neurostimulation Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: Europe: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: Germany: Neurostimulation Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: Germany: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 63: France: Neurostimulation Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 64: France: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 65: United Kingdom: Neurostimulation Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 66: United Kingdom: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 67: Italy: Neurostimulation Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 68: Italy: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 69: Spain: Neurostimulation Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 70: Spain: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 71: Russia: Neurostimulation Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 72: Russia: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 73: Others: Neurostimulation Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 74: Others: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 75: Asia Pacific: Neurostimulation Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 76: Asia Pacific: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 77: China: Neurostimulation Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 78: China: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 79: Japan: Neurostimulation Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 80: Japan: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 81: India: Neurostimulation Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 82: India: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 83: South Korea: Neurostimulation Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 84: South Korea: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 85: Australia: Neurostimulation Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 86: Australia: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 87: Indonesia: Neurostimulation Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 88: Indonesia: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 89: Others: Neurostimulation Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 90: Others: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 91: Latin America: Neurostimulation Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 92: Latin America: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 93: Brazil: Neurostimulation Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 94: Brazil: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 95: Mexico: Neurostimulation Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 96: Mexico: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 97: Others: Neurostimulation Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 98: Others: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 99: Middle East and Africa: Neurostimulation Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 100: Middle East and Africa: Neurostimulation Devices Market: Breakup by Country (in %), 2025
  • Figure 101: Middle East and Africa: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 102: Global: Neurostimulation Devices Industry: SWOT Analysis
  • Figure 103: Global: Neurostimulation Devices Industry: Value Chain Analysis
  • Figure 104: Global: Neurostimulation Devices Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Neurostimulation Devices Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Neurostimulation Devices Market Forecast: Breakup by Stimulation Type (in Million USD), 2026-2034
  • Table 3: Global: Neurostimulation Devices Market Forecast: Breakup by Device Type (in Million USD), 2026-2034
  • Table 4: Global: Neurostimulation Devices Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 5: Global: Neurostimulation Devices Market Forecast: Breakup by End-User (in Million USD), 2026-2034
  • Table 6: Global: Neurostimulation Devices Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 7: Global: Neurostimulation Devices Market: Competitive Structure
  • Table 8: Global: Neurostimulation Devices Market: Key Players